SPDR S&P Pharmaceuticals ETF
XPH
XPH
60 hedge funds and large institutions have $156M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 13 closing their positions.
Holders
60
Holders Change
-11
Holders Change %
-15.49%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
18
Reduced
23
Closed
13
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
Top Sellers
1 |
1
Goldman Sachs
New York
|
$25.9M |
2 |
2
Barclays
London,
United Kingdom
|
$8.38M |
3 |
3
Morgan Stanley
New York
|
$15.6M |
4 |
4
SG Americas Securities
New York
|
$0 |
5 |
5
Citigroup
New York
|
$272K |